Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Weerawan Chuenarom"'
Autor:
Denise C Hsu, Alexandra Schuetz, Rawiwan Imerbsin, Decha Silsorn, Amarendra Pegu, Dutsadee Inthawong, Jumpol Sopanaporn, Pornsuk Visudhiphan, Weerawan Chuenarom, Boot Keawboon, Wei Shi, Merlin L Robb, John R Mascola, Romas Geleziunas, Richard A Koup, Dan H Barouch, Nelson L Michael, Sandhya Vasan
Publikováno v:
PLoS Pathogens, Vol 17, Iss 2, p e1009339 (2021)
Toll-like receptor 7 (TLR7) agonist and PGT121 (broadly neutralizing antibody, bnAb) administration previously delayed viral rebound and induced SHIV remission. We evaluated the impact of GS-986 (TLR7 agonist) and dual bnAbs on viral rebound after an
Externí odkaz:
https://doaj.org/article/1bbb3787e2a04da0992cd09014e7ac62
Autor:
Piyathida Sroysuwan, Natthapol Kosashunhanan, Sebastian Molnar, Jerome H. Kim, Alexandra Schuetz, Taweewat Supindham, Elizabeth Heger, Sandhya Vasan, Phiromrat Rakyat, Suwat Chariyalertsak, Nittaya Phanuphak, Siriluck Teerachia, Suchada Chinaworapong, Nongluck Sangnoi, Oranitcha Kaewthip, Sorachai Nitayaphan, Surat Jongrakthaitae, Pornchanok Panjapornsuk, Michael A. Eller, Puttachard Saengtawan, Weerawan Chuenarom, Nuntisa Chotirosniramit, Pornsuk V. Grandin, Sirinan Madnote, Benjaluck Phonrat, Rungsun Rerknimitr, Narongrid Sirisopana, Lindsay Wieczorek, Siriwat Akapirat, Chirapa Eamsila, Faruk Sinangil, Kirsten Smith, James Tartaglia, Poonam Pegu, Dohoon Kim, Carter Lee, Peter Dawson, Saowanit Getchalarat, Robert J. O'Connell, Nicos Karasavvas, Jiraporn Puangkaew, Patcharaphan Sugandhavesa, Nitiya Chomchey, Punnee Pitisuttithum, Jean-Louis Excler, Boonlure Pruenglampoo, Yingjun Zhou, Yupa Sabmee, Jittima Dhitavat, Merlin L. Robb, Jesse Schoen, Victoria R. Polonis, Nelson L. Michael, Boot Kaewboon, Nipat Teeratakulpisarn, Bessara Nuntapinit, Wanlaya Labwech, Eugene Kroon, Viseth Ngauy, Prapaporn Savaraj, Jaranit Kaewkungwal, Pawinee Jarujareet, Nampueng Churikanont, Surawach Rittiroongrad, Somsak Chantakulkij, Anant Phramtong, Rapee Trichavaroj, Carlos A. DiazGranados, Silvia Ratto-Kim, Sanjay Phogat, Mark de Souza, Arom Pitisuthitham, Nipattra Tragonlugsana
Publikováno v:
Lancet HIV
BACKGROUND: The RV144 phase 3 vaccine trial in Thailand demonstrated that ALVAC-HIV (vCP1521) and AIDSVAX® B/E administration over six months resulted in a 31% efficacy in preventing HIV acquisition. In this trial, we assessed the immunologic impact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85f962459539bb0b1f931c1b9f15f516
https://europepmc.org/articles/PMC7247755/
https://europepmc.org/articles/PMC7247755/
Autor:
Supunnee Jirajariyavej, Weerawan Chuenarom, Nicholas Hutchings, Jintanat Ananworanich, Yuwadee Phuang-Ngern, Victor Valcour, Tanate Jadwattanakul, Duanghathai Suttichom, Silvia Ratto-Kim, Mark de Souza, Siriwat Akapirat, Peeriya Prueksakaew, Boot Kaewboon, Sukalaya Lerdlum, Somporn Tipsuk, Thep Chalermchai, John S. Barber, Pasiri Sithinamsuwan, Robert H. Paul, David Clifford, Chayada Sajjaweerawan, Jerome H. Kim, Alexandra Schuetz, James L. K. Fletcher, Mantana Pothisri, Putthachard Karnsomlap
Publikováno v:
AIDS Research and Human Retroviruses. 34:685-689
HIV-associated neurocognitive disorder (HAND) remains a challenge despite antiretroviral therapy (ART), and has been linked to monocyte/macrophage (M/M) migration to the brain. Due to the potential impact of T cell effector mechanisms in eliminating
Autor:
Jumpol Sopanaporn, Weerawan Chuenarom, Boot Keawboon, Dan H. Barouch, Wei Shi, John R. Mascola, Richard A. Koup, Merlin L. Robb, Sandhya Vasan, Rawiwan Imerbsin, Amarendra Pegu, Nelson L. Michael, Dutsadee Inthawong, Alexandra Schuetz, Pornsuk Visudhiphan, Decha Silsorn, Romas Geleziunas, Denise C. Hsu
Publikováno v:
PLoS Pathogens, Vol 17, Iss 2, p e1009339 (2021)
PLoS Pathogens
PLoS Pathogens
Toll-like receptor 7 (TLR7) agonist and PGT121 (broadly neutralizing antibody, bnAb) administration previously delayed viral rebound and induced SHIV remission. We evaluated the impact of GS-986 (TLR7 agonist) and dual bnAbs on viral rebound after an
Autor:
Claire Deleage, Denise C. Hsu, Eric Lombardini, Dutsadee Inthawong, Nelson L. Michael, Serena Spudich, Khamis Tomusange, Jacob D. Estes, Samir K. Lakhashe, Weerawan Chuenarom, Alexandra Schuetz, Lishomwa C. Ndhlovu, Robert J. O'Connell, Yuwadee Phuang-Ngern, Ruth M. Ruprecht, Jintanat Ananworanich, Piyanate Sunyakumthorn, Robin L. Burke, Yanin Kuncharin, Victor Valcour, Sandhya Vasan, Rawiwan Imerbsin, Merlin L. Robb, Decha Silsorn, Matthew D Wegner
Publikováno v:
Journal of Virology
Studies utilizing highly pathogenic simian immunodeficiency virus (SIV) and simian-human immunodeficiency virus (SHIV) have largely focused on the immunopathology of the central nervous system (CNS) during end-stage neurological AIDS and SIV encephal
Autor:
Weerawan Chuenarom, Sorachai Nitayaphan, Jerome H. Kim, Alexandra Schuetz, Nelson L. Michael, Mark de Souza, Supachai Rerks-Ngarm, Jeffrey R. Currier, Punnee Pitisuttithum, Somsak Chantakulkij, Jaranit Kaewkungwal, Bessara Nuntapinit, Anais Valencia-Micolta, Silvia Ratto-Kim, Bonnie J. Mathieson, Doris Thelian, Robert Paris, Mary A. Marovich
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 188(10)
The Thai HIV phase III prime/boost vaccine trial (RV144) using ALVAC-HIV (vCP1521) and AIDSVAX B/E was, to our knowledge, the first to demonstrate acquisition efficacy. Vaccine-induced, cell-mediated immune responses were assessed. T cell epitope map